The global BrainHealth Devices Market, By Device Type (Magnetic Resonance Imaging, MagnetoEncephalogram, Computed Tomography, Transcranial Doppler Device, and Others),by application (Stroke, Dementia, Epilepsy, Dyslexia, and Others), by end user(Hospitals, Specialty Clinics, and Others), and by region (North America, LatinAmerica, Europe, Asia Pacific, Middle East, and Africa), was valued at US$9,070.5 million in 2018, and isprojected to exhibit a CAGR of 7.7%, during the forecast period (2019-2026), ashighlighted in a new report published by.
Increasing number of regulatoryapprovals for the launch of brain health devices is expected to propel growthof the global brain health devices market. For instance, in March 2019,NeuroCatch Inc. received a Health Canada medical device license for itsNeuroCatch Platform, which is a rapid neuro-physiological brain functionassessment system. With the Health Canada medical device license, company isable to make the NeuroCatch Platform available for brain-focused clinicians andresearchers in Canada. Moreover, increasing prevalence of neurological conditionssuch as epilepsy, dementia, and Parkinson’s disease are expected to increasedemand for brain health devices which, in turn, is expected to contribute tothe market growth. For instance, according to the World Health Organization(WHO), in May 2019, around 50 million people across the globe were diagnosedwith dementia. According to the WHO estimation, on a global scale, 10 millionnew cases of dementia diagnosed every year. Furthermore, according to globalburden of Parkinson’s disease (published in the Neurology Lancet), in 2016, 6.1million people were diagnosed with Parkinson's disease around the world.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1095
Browse 23 Market Data Tables and19 Figures spread through 157 Pages and in-depth TOC on "Brain HealthDevices Market, By Device Type (Magnetic Resonance Imaging, MagnetoEncephalogram, Computed Tomography, Transcranial Doppler Device, and Others),by application (Stroke, Dementia, Epilepsy, Dyslexia, and Others), by end user(Hospitals, Specialty Clinics, and Others), and by region (North America, LatinAmerica, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to2026"
Increasing number of productlaunches by key players in the brain health devices market are driving growthof the brain health devices market. For instance, in June 2018, NeuroPace, Inc.launched its Next Gen RNS System for the treatment of refractory epilepsy. TheRNS System is a type of brain-computer interface intended to treat epilepticseizures by continuously monitoring brain waves, recognizing patient’s seizureonset fingerprint, and automatically responding with imperceptible electricalpulses before seizures occur. However, increasing number of product recalls areexpected to hamper growth of the brain health devices market. For instance, inSeptember 2018, the U.S. Food and Drug Administration (FDA) issued a productrecall notice for the Neuro Omega System including the Drive Headstage unit,developed by Alpha Omega Engineering, due to a risks related to improperelectrode connection, which could cause the device to adopt high electricalstimulation and damage brain tissue. Moreover, in the same year, the U.S. FDAissued a product recall notice for NeuroBlate System, developed by MonterisMedical, Inc. owing to issues such as unintended heating which can result inbrain damage and death. Thus, product recalls are estimated to hinder growth ofmarket and result in higher production costs for manufacturers as they have todiscard whole production batch following product defects.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/brain-health-devices-market-1095
Key Takeaways of the Global BrainHealth Devices Market:
The global brain health devicesmarket is expected to expand at a CAGR of 7.7% during the forecast period(2019–2026), owing to increasing focus on technological innovations by keyplayers to provide better patient outcomes. For instance, in January 2019,Boston Scientific Corporation launched its Vercise Primary Cell (PC) andVercise Gevia Deep Brain Stimulation (DBS) Systems featuring the VerciseCartesia Directional Lead. The new system has been designed to control therange, shape, position and direction of electrical stimulation to treatsymptoms of Parkinson's disease (PD) through highly-personalized therapy.
Increasing acquisitions by keyplayers are expected to drive growth of the global brain health devices market.For instance, in August 2015, Medtronic plc. acquired Medina Medical, developerof Medina Embolization Device (TM). With this acquisition, Medtronic hasstrengthened its hemorrhagic stroke product portfolio. The Medina EmbolizationDevice (TM) is an intrasaccular 3D mesh implant that fills the inside of a brainaneurysm.
Major players operating in theglobal brain health devices market include BrainScope Company, Inc., Bio-SignalGroup Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc.,Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic,GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., NeurowaveSystems Inc., Nihon Kohden Corporation, and Philips Healthcare.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1095
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
